Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells.

Ding Y, Gao H, Zhang Y, Li Y, Vasdev N, Gao Y, Chen Y, Zhang Q

Open source

DOI
10.1186/s13045-016-0327-5
Published
2016 Sep 22
Container
Journal of hematology & oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13045-016-0327-5,
  title = {Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells.},
  author = {Ding Y and Gao H and Zhang Y and Li Y and Vasdev N and Gao Y and Chen Y and Zhang Q},
  year = {2016},
  journal = {Journal of hematology \& oncology},
  doi = {10.1186/s13045-016-0327-5},
  url = {https://doi.org/10.1186/s13045-016-0327-5}
}

RIS

TY  - JOUR
TI  - Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells.
AU  - Ding Y
AU  - Gao H
AU  - Zhang Y
AU  - Li Y
AU  - Vasdev N
AU  - Gao Y
AU  - Chen Y
AU  - Zhang Q
PY  - 2016
JO  - Journal of hematology & oncology
DO  - 10.1186/s13045-016-0327-5
UR  - https://doi.org/10.1186/s13045-016-0327-5
ER  - 

APA

Y, D., H, G., Y, Z., Y, L., N, V., Y, G., Y, C., & Q, Z. (2016). Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells.. Journal of hematology & oncology. https://doi.org/10.1186/s13045-016-0327-5

Source records